Bluejay Diagnostics, Inc. (BJDX)
1.899
-0.06
(-3.11%)
USD |
NASDAQ |
Apr 24, 16:00
1.92
+0.02
(+1.12%)
After-Hours: 20:00
Bluejay Diagnostics EPS Diluted (Quarterly) : -2.365 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -1.03 |
| Atossa Therapeutics, Inc. | -1.270 |
| Abeona Therapeutics, Inc. | -0.3717 |
| Cell Source, Inc. | -0.0153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.430M |
| Total Expenses (Quarterly) | 1.430M |
| Enterprise Value | -3.071M |
| Earnings Yield | -812.7% |
| Normalized Earnings Yield | -812.69 |